Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients

Fig. 4

Kaplan-Meier curves showing the probability of disease-free survival, according to MUC2 expression and DNA MMR status: a MMR-proficient and b MMR-deficient cases. The log-rank test was used to test for differences in survival between cases with high and low expression of MUC2, while univariable Cox regression (Wald) was used to generate hazard ratios (HR) and 95% confidence intervals (CI), after adjustment for sex and tumor grade

Back to article page
\